Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Leavitt Gets Nomination By Bush As New Head Of HHS

Dec. 14, 2004

By Aaron Lorenzo

Leavitt Gets Nomination By Bush As New Head Of HHS

Dec. 14, 2004

By Aaron Lorenzo

QuatRx Raises $31M In Third Round For Growing Pipeline

Dec. 14, 2004

By Aaron Lorenzo

Hawaii Biotech Gets $15.5M In NIH Funding For Vaccines

Dec. 13, 2004

By Aaron Lorenzo

Hawaii Biotech Gets $15.5M In NIH Funding For Vaccines

Dec. 13, 2004

By Aaron Lorenzo

Nastech Triples Cash With Public Sale Worth $57.4M

Dec. 10, 2004

By Aaron Lorenzo

Padding its savings account and then some, Nastech Pharmaceutical Co. Inc. raised about $57.4 million in gross proceeds through a public offering. (BioWorld Today)

Nastech Triples Cash With Public Sale Worth $57.4M

Dec. 10, 2004

By Aaron Lorenzo

Padding its savings account and then some, Nastech Pharmaceutical Co. Inc. raised about $57.4 million in gross proceeds through a public offering. (BioWorld Today)

Liquidating Triad Sells P38 Program For Up To $66M

Dec. 9, 2004

By Aaron Lorenzo

Liquidating Triad Sells P38 Program For Up To $66M

Dec. 9, 2004

By Aaron Lorenzo

Endocyte Brings In $22.6M To Advance 'Smart Drugs'

Dec. 8, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...